REGENERON PHARMACEUTICALS, INC. Quarterly Nonoperating Income (Expense) in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Regeneron Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2010 to Q3 2024.
  • Regeneron Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $314M.
  • Regeneron Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $996M, a 541% increase year-over-year.
  • Regeneron Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was $152M, a 26.9% increase from 2022.
  • Regeneron Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was $120M, a 68.4% decline from 2021.
  • Regeneron Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2021 was $379M, a 62.1% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $996M $314M +$314M Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $682M $559M +$492M +741% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $190M -$50.7M +$38M +42.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $152M $175M -$3.2M -1.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-05
Q3 2023 $155M -$200K -$286M -100% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 $442M $66.4M +$213M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $229M -$88.7M +$109M +55.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $120M $178M +$314M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-05
Q3 2022 -$194M $286M +$317M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 -$511M -$147M -$552M -136% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $41.3M -$197M -$338M -241% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $379M -$136M -$194M -337% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-05
Q3 2021 $573M -$30.6M +$24.2M +44.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $549M $406M +$143M +54.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $406M $140M +$172M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $234M $57.6M -$157M -73.1% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-06
Q3 2020 $390M -$54.8M -$84.8M -283% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $475M $263M +$353M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $122M -$31.5M -$97.6M -148% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $219M $214M +$256M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-07
Q3 2019 -$36.8M $30M +$21M +233% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$57.8M -$90.9M -$125M -368% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $67M $66.1M +$47.9M +263% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
Q4 2018 $19.1M -$42M -$57.9M -364% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-08
Q3 2018 $77M $9M +$3.32M +58.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 $73.7M $33.9M +$58.4M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $15.4M $18.2M +$16.5M +942% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 -$1.1M $15.9M +$21.4M Oct 1, 2017 Dec 31, 2017 10-K 2020-02-07
Q3 2017 -$22.5M $5.68M +$2.6M +84.4% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 -$25.1M -$24.5M -$25.1M -3995% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 $4K $1.75M +$904K +107% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-03
Q4 2016 -$900K -$5.45M -$1.66M -43.7% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-07
Q3 2016 $757K $3.08M +$2.21M +255% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 -$1.46M $628K +$17.5M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 -$18.9M $843K +$7.87M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 -$26.8M -$3.79M +$22.3M +85.5% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-08
Q3 2015 -$49.1M $867K +$7.51M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 -$56.6M -$16.9M +$2.42M +12.6% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 -$59M -$7.03M +$3.65M +34.2% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 -$62.7M -$26.1M -$12.2M -87.4% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-09
Q3 2014 -$50.5M -$6.64M +$4.48M +40.3% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-04
Q2 2014 -$55M -$19.3M -$8.88M -85.3% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-04
Q1 2014 -$46.1M -$10.7M +$543K +4.84% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 -$46.7M -$13.9M -$2.81M -25.3% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-11
Q3 2013 -$43.9M -$11.1M -$222K -2.04% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-04
Q2 2013 -$43.6M -$10.4M +$324K +3.02% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-05
Q1 2013 -$44M -$11.2M -$669K -6.34% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 -$43.3M -$11.1M -$2.46M -28.4% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-12
Q3 2012 -$40.8M -$10.9M -$7.55M -226% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-05
Q2 2012 -$33.3M -$10.7M -$7.69M -252% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-06
Q1 2012 -$25.6M -$10.6M -$7.87M -293% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-03
Q4 2011 -$17.7M -$8.66M -$6.84M -376% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-13
Q3 2011 -$10.9M -$3.35M -$1.57M -87.9% Jul 1, 2011 Sep 30, 2011 10-Q 2012-10-24
Q2 2011 -$9.33M -$3.05M -$1.3M -74.2% Apr 1, 2011 Jun 30, 2011 10-Q 2012-07-25
Q1 2011 -$8.03M -$2.68M -$1.04M -63% Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-26
Q4 2010 -$7M -$1.82M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-15
Q3 2010 -$1.78M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-27
Q2 2010 -$1.75M Apr 1, 2010 Jun 30, 2010 10-Q 2011-07-28
Q1 2010 -$1.65M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.